Skip to main content

Table 3 Laboratory test results of immunosuppressed patients with influenza infections

From: Clinical characteristics, risk factors and antiviral treatments of influenza in immunosuppressed inpatients in Beijing during the 2015–2020 influenza seasons

 

All types (n = 111)

Malignancies (n = 71)

HSCT (n = 26)

Autoimmune disorders (n = 10)

WBC* (× 109/L)

5.0 (0.0–64.7)

5.2 (0.2–64.7)

3.3 (0.0–13.5)

6.0 (0.9–8.5)

Neutrophils (%)

71.2 (0.0–96.4)

71.2 (0.0–96.4)

71.9 (0.5–96.4)

72.8 (58.0–89.8)

Neutrophils (× 109/L)

3.6 (0.0–63.7)

3.8 (0.0–63.7)

3.0 (0.0–12.7)

4.2 (0.5–7.6)

Lymphocytes (%)

15.6 (1.4–97.4)

15.8 (1.8–97.4)

15.0 (1.4–60.9)

16.6 (3.1–33.8)

Lymphocytes (× 109/L)

0.7 (0.0–58.1)

0.7 (0.0–58.1)

0.7 (0.0–2.0)

0.7 (0.3–1.7)

Platelets (× 109/L)

118.0 (8.0–429.0)

149.0 (8.0–429.0)

78.0 (8.0–217.0)

156.5 (28.0–313.0)

Alanine aminotransferase (U/L)

21.0 (2.0–279.0)

19.0 (6.0–279.0)

22.0 (2.0–182.0)

16.5 (8.0–28.0)

Aspartate aminotransferase (U/L)

22.0 (6.0–198.0)

20.5 (6.0–198.0)

24.0 (11.0–182.0)

24.0 (15.0–45.0)

Albumin (g/L)

33.7 (20.1–48.7)

35.1 (20.1–48.7)

33.1 (24.4–42.5)

35.1 (29.3–36.9)

Lactate dehydrogenase (U/L)

190.0 (77.0–5536.0)

186.0 (77.0–5536.0)

280.0 (169.0–890.0)

168.0 (154.0–229.0)

Creatine kinase (U/L)

29.0 (4.0–725.0)

35.0 (4.0–725.0)

23.0 (6.0–157.0)

19.0 (13.0–29.0)

Blood creatinine (µmol/L)

59.0 (22.0–1189.0)

58.0 (22.0–178.0)

58.5 (23.0–139.0)

59.0 (30.0–84.0)

FiO2 (mmHg)

360.9 (97.5–512.6)

323.3 (179.3–457.4)

338.3 (97.5–472.1)

431.7 (350.8–512.6)

Lactic acid (mmol/L)

1.2 (0.4–2.6)

1.1 (0.9–1.6)

1.7 (0.4–2.6)

0.8 (0.6–1.0)

Erythrocyte sedimentation rate (mm/h)

31.5 (9.0–123.0)

32.0 (9.0–123.0)

16.0 (15.0–18.0)

27.5 (16.0–68.0)

C-reactive protein (mg/L)

27.7 (0.5–416.9)

48.3 (0.5–416.9)

12.8 (0.5–139.1)

11.26 (0.5–105.83)

  1. *WBC: white blood cell